Alex Fässler

Chief Operating Officer at

Targimmune Therapeutics AG

Net worth: 3 M $ as of 2026-06-29

71 year

8 connections

Health Technology

Consumer Services

Profile

Alex Fässler is currently the Head of Operations at Targimmune Therapeutics AG.
Previously, he worked as the Chief Operating Officer at Bachem Holding AG and as the Head of Production & Site Manager at Bachem AG.
He holds a doctorate degree from the Swiss Federal Institute of Technology.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BACHEM HOLDING AG CLASS B 0.04%	2025-12-30	33,580 ( 0.04% )	3 M $	2026-06-29

Alex Fässler active positions

Companies	Position	Start
Targimmune Therapeutics AG Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies	Chief Operating Officer	-

All active positions of Alex Fässler

Former positions of Alex Fässler

Companies	Position	End
Bachem AG Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products	Corporate Officer/Principal	-
BACHEM HOLDING AG	Chief Operating Officer	-

See the detail of Alex Fässler's experience

Training of Alex Fässler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alex Fässler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Bachem Holding AG Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company	Health Technology
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bachem AG Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products	Health Technology
Targimmune Therapeutics AG Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies	Health Technology